Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+/EpCAM+ phenotype: a promising target for preventing progression of TNBC
Crossref DOI link: https://doi.org/10.1186/s12885-017-3592-y
Published Online: 2017-09-04
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brugnoli, Federica
Grassilli, Silvia
Lanuti, Paola
Marchisio, Marco
Al-Qassab, Yasamin
Vezzali, Federica
Capitani, Silvano
Bertagnolo, Valeria
Funding for this research was provided by:
Italian MIUR (FIRB RBAP10Z7FS_002)